Living with and beyond cancer research post-pandemic

What have we learnt?

This session from the National Cancer Research Institute, co-chaired by Professor Claire Foster from the University of Southampton, and Dr Kate Absolom from the British Psychosocial Oncology Society, will focus on how the COVID-19 pandemic has disrupted social and applied health research practices by challenging researchers to reconsider their designs, ethics and recruitment strategies. Speakers will cover issues such as navigating and conducting fieldwork, experiences of conducting large-scale programme grants, and trial design to optimise research delivery in the context of COVID-19.

By the end of this session, participants will have learnt more about the difficulties that researchers continue to face in response to the pandemic, how research practices have adapted, and how approaches may be irreversibly changed moving forward (such as increased use of virtual and digital platforms).

Speakers:

• Ms Michelle Collinson – University of Leeds, UK (Trial design and methodologies in a pandemic)
• Dr Alexandra Gilbert – Leeds Cancer Centre, UK (Trial design and methodologies in a pandemic)
• Professor Eila Watson – Oxford Brookes University, UK (SWEET Programme)
• Professor Deborah Lupton – University of New South Wales, Australia (Doing fieldwork in a pandemic)